Putu Satyakumara Upadhana, I. G. A. Sastrawan, I. G. A. G. D. Rahmautami, Merry Merry, Ni Putu Kostarika Melia Daradila, Derian Adiguna Sutanto, Ida Ayu Chandranita Manuaba, Putu Ardy Hartadi, Komang Vika Nariswari Ratna Kinasih, Putu Sudarmika, I. M. Semadi, I. K. A. Somia
{"title":"2型糖尿病与20-2022年slamation hospital COVID-19患者之间的关系","authors":"Putu Satyakumara Upadhana, I. G. A. Sastrawan, I. G. A. G. D. Rahmautami, Merry Merry, Ni Putu Kostarika Melia Daradila, Derian Adiguna Sutanto, Ida Ayu Chandranita Manuaba, Putu Ardy Hartadi, Komang Vika Nariswari Ratna Kinasih, Putu Sudarmika, I. M. Semadi, I. K. A. Somia","doi":"10.7454/jpdi.v9i2.774","DOIUrl":null,"url":null,"abstract":"Introduction. People with type 2 diabetes mellitus (T2DM) are at a higher risk of mortality from COVID-19. This study aimed to identify the relationship between T2DM and the outcome of COVID-19 patients in Sanglah Hospital Denpasar, Bali. Methods. An observational analytic study with a cross-sectional approach was conducted among COVID-19 patients. We used secondary data from the records of confirmed COVID-19 patients who were treated at Sanglah Hospital on 1 August 2020 – 28 February 2022. Sample were selected with total sampling technique. Results. There were 1,056 patients involved in this study. Most of the patients were male (n=571; 54.1%), with a median age of 59 years old. Most of the patients were categorized as severe COVID-19 (n=641; 60.7%). A total of 275 patients had T2DM (26.0%). Chi-square analysis showed a significant association of T2DM with mortality (PR=1.422; 95%CI=1.162-1.742; p=0.001), severe COVID-19 (PR=1.726; 95%CI=1.365-2.184; p<0.001), ventilator usage (PR=1.334; 95%CI=1.093-1.791; p=0.045), Conclusion. There is a significant association between T2DM with mortality risk, severe COVID-19, and longer hospitalization duration in COVID-19 patients.","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Hubungan antara Diabetes Melitus Tipe 2 terhadap Luaran Pasien COVID-19 di Rumah Sakit Sanglah pada Tahun 2020-2022\",\"authors\":\"Putu Satyakumara Upadhana, I. G. A. Sastrawan, I. G. A. G. D. Rahmautami, Merry Merry, Ni Putu Kostarika Melia Daradila, Derian Adiguna Sutanto, Ida Ayu Chandranita Manuaba, Putu Ardy Hartadi, Komang Vika Nariswari Ratna Kinasih, Putu Sudarmika, I. M. Semadi, I. K. A. Somia\",\"doi\":\"10.7454/jpdi.v9i2.774\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction. People with type 2 diabetes mellitus (T2DM) are at a higher risk of mortality from COVID-19. This study aimed to identify the relationship between T2DM and the outcome of COVID-19 patients in Sanglah Hospital Denpasar, Bali. Methods. An observational analytic study with a cross-sectional approach was conducted among COVID-19 patients. We used secondary data from the records of confirmed COVID-19 patients who were treated at Sanglah Hospital on 1 August 2020 – 28 February 2022. Sample were selected with total sampling technique. Results. There were 1,056 patients involved in this study. Most of the patients were male (n=571; 54.1%), with a median age of 59 years old. Most of the patients were categorized as severe COVID-19 (n=641; 60.7%). A total of 275 patients had T2DM (26.0%). Chi-square analysis showed a significant association of T2DM with mortality (PR=1.422; 95%CI=1.162-1.742; p=0.001), severe COVID-19 (PR=1.726; 95%CI=1.365-2.184; p<0.001), ventilator usage (PR=1.334; 95%CI=1.093-1.791; p=0.045), Conclusion. There is a significant association between T2DM with mortality risk, severe COVID-19, and longer hospitalization duration in COVID-19 patients.\",\"PeriodicalId\":32700,\"journal\":{\"name\":\"Jurnal Penyakit Dalam Indonesia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Penyakit Dalam Indonesia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7454/jpdi.v9i2.774\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Penyakit Dalam Indonesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7454/jpdi.v9i2.774","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hubungan antara Diabetes Melitus Tipe 2 terhadap Luaran Pasien COVID-19 di Rumah Sakit Sanglah pada Tahun 2020-2022
Introduction. People with type 2 diabetes mellitus (T2DM) are at a higher risk of mortality from COVID-19. This study aimed to identify the relationship between T2DM and the outcome of COVID-19 patients in Sanglah Hospital Denpasar, Bali. Methods. An observational analytic study with a cross-sectional approach was conducted among COVID-19 patients. We used secondary data from the records of confirmed COVID-19 patients who were treated at Sanglah Hospital on 1 August 2020 – 28 February 2022. Sample were selected with total sampling technique. Results. There were 1,056 patients involved in this study. Most of the patients were male (n=571; 54.1%), with a median age of 59 years old. Most of the patients were categorized as severe COVID-19 (n=641; 60.7%). A total of 275 patients had T2DM (26.0%). Chi-square analysis showed a significant association of T2DM with mortality (PR=1.422; 95%CI=1.162-1.742; p=0.001), severe COVID-19 (PR=1.726; 95%CI=1.365-2.184; p<0.001), ventilator usage (PR=1.334; 95%CI=1.093-1.791; p=0.045), Conclusion. There is a significant association between T2DM with mortality risk, severe COVID-19, and longer hospitalization duration in COVID-19 patients.